Orthobiology is a field of science which is engaged in manufacturing the bone and tissue replacement materials for fast healing and quick recovery of injured muscles, broken bones, ligaments and tendons. Orthobiologics is considered as a highly lucrative market due to many growth opportunities.

Orthobiologics are substances, available in the human body for faster healing process of injuries such as, broken bones, injured muscles, and ligaments. The substances are used in higher concentration for accelerating healing process.

Increasing prevalence of spinal disorders, rising cases of sports injuries & road accidents and growing preference of patients for minimally invasive procedures are expected to drive the growth of the market in the coming years. Rise in the emerging nations and government initiatives & funds is expected to offer growth opportunities for the manufacturers operating in the orthobiologics market during the forecast period.

The "Global Orthobiologics Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a focus on the global orthobiologics market trend. The report aims to provide an overview of global orthobiologics market with detailed market segmentation by product, application, end user and geography. The global orthobiologics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the orthobiologics market.

The global orthobiologics market is segmented on the basis of product, application and end user. Based on product, the orthobiologics market is categorized as, demineralized bone matrices, viscosupplementation products, synthetic orthobiologics, allografts, bone morphogenic protein, and others. On the basis of application, spinal fusion, osteoarthritis & degenerative arthritis, soft-tissue injuries, and others. On the basis of end user, the orthobiologics market is segmented as, hospitals, orthopedic clinics and other end users.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global orthobiologics market based on product, application and end user. It also provides market size and forecast till 2028 for overall orthobiologics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America and Europe dominates the orthobiologics market. The dominance is because of increase in prevalence of arthritis and higher obesity rates that has surged the demand for minimally invasive procedures such as bone grafting and growth factor treatment. However, Asia Pacific is expected to register the highest growth rate during the forecast period due to large geriatric and target patient population, high incidence of osteoarthritis & obesity, increasing government spending on healthcare, and improving healthcare infrastructure.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key orthobiologics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, Johnson & Johnson Services, Inc., Stryker, Zimmer Biomet, Globus Medical, Inc., Orthofix International N.V., RTI Surgical, Inc., Kuros Biosciences Ltd., K2M Group Holdings, Inc., and Nuvasive, Inc. among others.